Global Women's Health Therapeutics Market Size study & Forecast, by Type( Infection, Pregnancy, Oncology) and Regional Analysis, 2022-2029

Description

List of Tables

Global Women's Health Therapeutics Market is valued approximately USD 151.33 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 10.0% over the forecast period 2022-2029. Medical procedures, tools, and services aimed at identifying and enhancing women's health are referred to as therapeutics for women's health. The Women's Health Therapeutics market is expanding because of factors such as growing incidence of chronic health conditions among women, demand for contraceptives to prevent unintended pregnancies. In addition, rising healthcare spending for cancer and infectious disease early detection, pregnancy-related difficulties, and the introduction of new and potent medications are projected to further propel the market.

According to report from world health organization, in 2020, there were 2.3 million women diagnosed with breast cancer which increased from 1.68 million in year 2012. Furthermore, According to a research article by Guttmacher Institute in March 2021, it was estimated that approximately 2.4 million of adolescent women in India want to avoid pregnancy and in need of modern contraception. Thus, the rise in prevalence of cancer and demand for Contraceptives to Prevent Unintended Pregnancies is fostering the market growth. In addition, growing awareness and introduction of new drug therapies, High prevalence of infectious diseases among women is creating a lucrative growth to the market. However, the high cost of Women's Health Therapeutics stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Women's Health Therapeutics Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. Asia Pacific dominated the market in terms of revenue, owing to the dominance of branded products, rising target population, rising investment in product development activities. Whereas North America is expected to grow with a highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, an increase in the number of collaborations for biosimilar development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.

Major market players included in this report are:

Bayer AG
Merck & Co., Inc.
Pfizer, Inc.
Teva Pharmaceutical Industries Ltd.
AstraZeneca
Bristol-Myers Squibb Company
Eli Lilly and Company
Novartis AG
GlaxoSmithKline plc
F. Hoffmann-La Roche Ltd

Recent Developments in the Market:

In January 2021, to prevent postpartum bleeding, Sun Pharmaceutical Industries Ltd. and Ferring Pharmaceuticals Pvt. Ltd. launched the obstetric medication CARITEC in India.
In May 2018, Pfizer initiated a Phase III trial for the ovarian cancer drug Avelumab, which can be used in conjunction with chemotherapy. This is anticipated to increase their treatment offerings and provide communities and customers with top-notch care.

Global Women's Health Therapeutics Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Type, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Type offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

Infection
Pregnancy
Oncology

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World

Chapter 1. Executive Summary

1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
- 1.2.1. Women's Health Therapeutics Market, by Region, 2019-2029 (USD Billion)
- 1.2.2. Women's Health Therapeutics Market, by Type, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Global Women's Health Therapeutics Market Definition and Scope

2.1. Objective of the Study
2.2. Market Definition & Scope
- 2.2.1. Scope of the Study
- 2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Global Women's Health Therapeutics Market Dynamics

3.1. Women's Health Therapeutics Market Impact Analysis (2019-2029)
- 3.1.1. Market Drivers
  - 3.1.1.1. Growing Incidence of Chronic Health Conditions Among Women
  - 3.1.1.2. Demand for Contraceptives to Prevent Unintended Pregnancies
- 3.1.2. Market Challenges
  - 3.1.2.1. High cost of therapies
- 3.1.3. Market Opportunities
  - 3.1.3.1. Growing awareness and introduction of new drug therapies
  - 3.1.3.2. High prevalence of infectious diseases among women

Chapter 4. Global Women's Health Therapeutics Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Women's Health Therapeutics Market, by Type

6.1. Market Snapshot
6.2. Global Women's Health Therapeutics Market by Type, Performance - Potential Analysis
6.3. Global Women's Health Therapeutics Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
6.4. Women's Health Therapeutics Market, Sub Segment Analysis
- 6.4.1. Infection
- 6.4.2. Pregnancy
- 6.4.3. Oncology

Chapter 7. Global Women's Health Therapeutics Market, Regional Analysis

7.1. Women's Health Therapeutics Market, Regional Market Snapshot
7.2. North America Women's Health Therapeutics Market
- 7.2.1. U.S. Women's Health Therapeutics Market
  - 7.2.1.1. Product breakdown estimates & forecasts, 2019-2029
- 7.2.2. Canada Women's Health Therapeutics Market
7.3. Europe Women's Health Therapeutics Market Snapshot
- 7.3.1. U.K. Women's Health Therapeutics Market
- 7.3.2. Germany Women's Health Therapeutics Market
- 7.3.3. France Women's Health Therapeutics Market
- 7.3.4. Spain Women's Health Therapeutics Market
- 7.3.5. Italy Women's Health Therapeutics Market
- 7.3.6. Rest of Europe Women's Health Therapeutics Market
7.4. Asia-Pacific Women's Health Therapeutics Market Snapshot
- 7.4.1. China Women's Health Therapeutics Market
- 7.4.2. India Women's Health Therapeutics Market
- 7.4.3. Japan Women's Health Therapeutics Market
- 7.4.4. Australia Women's Health Therapeutics Market
- 7.4.5. South Korea Women's Health Therapeutics Market
- 7.4.6. Rest of Asia Pacific Women's Health Therapeutics Market
7.5. Latin America Women's Health Therapeutics Market Snapshot
- 7.5.1. Brazil Women's Health Therapeutics Market
- 7.5.2. Mexico Women's Health Therapeutics Market
- 7.5.3. Rest of Latin America Women's Health Therapeutics Market
7.6. Rest of The World Women's Health Therapeutics Market

Chapter 8. Competitive Intelligence

8.1. Top Market Strategies
8.2. Company Profiles
- 8.2.1. Bayer AG
  - 8.2.1.1. Key Information
  - 8.2.1.2. Overview
  - 8.2.1.3. Financial (Subject to Data Availability)
  - 8.2.1.4. Product Summary
  - 8.2.1.5. Recent Developments
- 8.2.2. Merck & Co., Inc.
- 8.2.3. Pfizer, Inc.
- 8.2.4. Teva Pharmaceutical Industries Ltd.
- 8.2.5. AstraZeneca
- 8.2.6. Bristol-Myers Squibb Company
- 8.2.7. Eli Lilly and Company
- 8.2.8. Novartis AG
- 8.2.9. GlaxoSmithKline plc
- 8.2.10. F. Hoffmann-La Roche Ltd

Chapter 9. Research Process

9.1. Research Process
- 9.1.1. Data Mining
- 9.1.2. Analysis
- 9.1.3. Market Estimation
- 9.1.4. Validation
- 9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption

LIST OF TABLES

TABLE 1. Global Women's Health Therapeutics Market, report scope
TABLE 2. Global Women's Health Therapeutics Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Women's Health Therapeutics Market estimates & forecasts by Product 2019-2029 (USD Billion)
TABLE 4. Global Women's Health Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 5. Global Women's Health Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 6. Global Women's Health Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Women's Health Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Women's Health Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Women's Health Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Women's Health Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Women's Health Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Women's Health Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Women's Health Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. U.S. Women's Health Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. U.S. Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 16. U.S. Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 17. Canada Women's Health Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 18. Canada Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 19. Canada Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 20. UK Women's Health Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 21. UK Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 22. UK Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 23. Germany Women's Health Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 24. Germany Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 25. Germany Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 26. France Women's Health Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 27. France Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 28. France Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 29. Italy Women's Health Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 30. Italy Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 31. Italy Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 32. Spain Women's Health Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 33. Spain Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 34. Spain Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 35. RoE Women's Health Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 36. RoE Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 37. RoE Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 38. China Women's Health Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 39. China Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 40. China Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 41. India Women's Health Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 42. India Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 43. India Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 44. Japan Women's Health Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 45. Japan Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 46. Japan Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 47. South Korea Women's Health Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 48. South Korea Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 49. South Korea Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 50. Australia Women's Health Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 51. Australia Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 52. Australia Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 53. RoAPAC Women's Health Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 54. RoAPAC Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 55. RoAPAC Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 56. Brazil Women's Health Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 57. Brazil Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 58. Brazil Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 59. Mexico Women's Health Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 60. Mexico Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 61. Mexico Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 62. RoLA Women's Health Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 63. RoLA Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 64. RoLA Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 65. Row Women's Health Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 66. Row Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 67. Row Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 68. List of secondary sources, used in the study of global Women's Health Therapeutics Market
TABLE 69. List of primary sources, used in the study of global Women's Health Therapeutics Market
TABLE 70. Years considered for the study
TABLE 71. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

FIG 1. Global Women's Health Therapeutics Market, research methodology
FIG 2. Global Women's Health Therapeutics Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Women's Health Therapeutics Market, key trends 2021
FIG 5. Global Women's Health Therapeutics Market, growth prospects 2022-2029
FIG 6. Global Women's Health Therapeutics Market, porters 5 force model
FIG 7. Global Women's Health Therapeutics Market, pest analysis
FIG 8. Global Women's Health Therapeutics Market, value chain analysis
FIG 9. Global Women's Health Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Women's Health Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Women's Health Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Women's Health Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Women's Health Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Women's Health Therapeutics Market, regional snapshot 2019 & 2029
FIG 15. North America Women's Health Therapeutics Market 2019 & 2029 (USD Billion)
FIG 16. Europe Women's Health Therapeutics Market 2019 & 2029 (USD Billion)
FIG 17. Asia pacific Women's Health Therapeutics Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Women's Health Therapeutics Market 2019 & 2029 (USD Billion)
FIG 19. Global Women's Health Therapeutics Market, company Market share analysis (2021)